TCRT - Alaunos Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-12    (Delayed quote data   2025-01-03)
Last
 2.05		 Change
 ⇑ +0.08   (+4.06%)		 Volume
  6,408
Open
 2.00		 High
 2.08		 Low
 2.00
8EMA (Daily)
 1.99		 40EMA (Daily)
 2.12		 50EMA (Daily)
 2.16		 STO (Daily)
 55.936		 MACD Hist (Daily)
 0.028
8EMA (Weekly)
 2.070		 40EMA (Weekly)
 1.94		 50EMA (Weekly)
 1.83		 STO (Weekly)
 11.139		 MACD Hist (Weekly)
 -0.159
Company Profile
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com